Get the Stockscreener App
221.75
1.85%
4.02
Pre-market:
222.80
1.05
+0.47%
Krystal Biotech Inc stock is traded at $221.75, with a volume of 316.41K.
It is up +1.85% in the last 24 hours and up +9.10% over the past month.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
See More
Previous Close:
$217.73
Open:
$215.8
24h Volume:
316.41K
Relative Volume:
1.03
Market Cap:
$6.43B
Revenue:
$290.51M
Net Income/Loss:
$89.16M
P/E Ratio:
74.16
EPS:
2.99
Net Cash Flow:
$119.18M
1W Performance:
+1.39%
1M Performance:
+9.10%
6M Performance:
+67.95%
1Y Performance:
+18.19%
1-Day Range:
$213.83
$222.66
1-Week Range:
$212.75
$222.66
52-Week Range:
$122.80
$222.66
Krystal Biotech Inc Stock (KRYS) Company Profile
Name
Krystal Biotech Inc
Sector
Industry
Phone
(412) 586-5830
Address
2100 WHARTON STREET, PITTSBURGH, PA
Compare KRYS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KRYS
Krystal Biotech Inc
|
221.75 | 6.31B | 290.51M | 89.16M | 119.18M | 2.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Krystal Biotech Inc Stock (KRYS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-25 | Initiated | Jefferies | Buy |
| Aug-06-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-20-23 | Initiated | Goldman | Buy |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-12-23 | Initiated | Citigroup | Buy |
| Sep-07-23 | Initiated | Berenberg | Buy |
| Apr-18-23 | Initiated | Stifel | Buy |
| Feb-28-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-25-22 | Downgrade | Goldman | Buy → Neutral |
| Jan-18-22 | Initiated | BofA Securities | Buy |
| Jul-20-21 | Upgrade | Goldman | Neutral → Buy |
| Sep-18-20 | Initiated | B. Riley FBR | Buy |
| Jun-04-20 | Initiated | Evercore ISI | Outperform |
| Sep-24-19 | Initiated | Goldman | Neutral |
| Aug-06-19 | Reiterated | H.C. Wainwright | Buy |
| Jun-24-19 | Reiterated | Chardan Capital Markets | Buy |
| Jun-24-19 | Reiterated | H.C. Wainwright | Buy |
| May-30-19 | Initiated | Guggenheim | Buy |
| Sep-11-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Krystal Biotech Inc Stock (KRYS) Latest News
Edgestream Partners L.P. Buys Shares of 19,678 Krystal Biotech, Inc. $KRYS - MarketBeat
Why Krystal Biotech Inc. stock could rally in 2025Trade Entry Report & Entry Point Strategy Guides - Newser
How Krystal Biotech Inc. stock reacts to oil pricesWeekly Market Summary & Stock Market Timing Techniques - Newser
Krystal Biotech stock hits all-time high of 221.91 USD - Investing.com
Will Krystal Biotech Inc. stock outperform growth indexes2025 Key Highlights & High Conviction Investment Ideas - Newser
Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? - The Motley Fool
Is Krystal Biotech Inc. (4KB) stock considered safe havenJuly 2025 Update & AI Driven Price Predictions - Newser
Will Krystal Biotech Inc. (4KB) stock issue positive guidance2025 Fundamental Recap & Daily Technical Forecast Reports - Newser
How Krystal Biotech Inc. (4KB) stock trades after earnings2025 Trading Recap & Daily Growth Stock Investment Tips - Newser
Will Krystal Biotech Inc. (4KB) stock announce a stock splitJuly 2025 Movers & Comprehensive Market Scan Insights - Newser
Creative Planning Has $1.15 Million Position in Krystal Biotech, Inc. $KRYS - MarketBeat
Is TTK Prestige Limited Undervalued or Overvalued Fair Value ExplainedMarket Liquidity Analysis & Discover Strategies with Fellow Traders - earlytimes.in
Price-Driven Insight from (KRYS) for Rule-Based Strategy - news.stocktradersdaily.com
Pharma News: Will Krystal Biotech Inc. stock benefit from AI adoptionWatch List & Stepwise Swing Trade Plans - BỘ NỘI VỤ
Will Krystal Biotech Inc. stock benefit from AI adoptionWeekly Gains Report & Daily Momentum Trading Reports - BỘ NỘI VỤ
Krystal Biotech (NASDAQ:KRYS) Reaches New 1-Year HighWhat's Next? - MarketBeat
Krystal Biotech’s Profits Rose As Vyjuvek Reached New Markets - Finimize
Krystal Biotech, Inc. (KRYS) Stock Forecasts - Yahoo Finance
Why Krystal Biotech Inc. stock is considered a top pickTreasury Yields & Detailed Earnings Play Alerts - BỘ NỘI VỤ
Krystal Biotech, Inc. to Participate in 8th Annual Evercore Healthcare Conference on December 3, 2025 - Quiver Quantitative
Krystal Biotech to Present at 8th Annual Evercore Healthcare Conference - The Manila Times
Krystal Biotech (NASDAQ: KRYS) at 8th Evercore Conference with 10:00 a.m. ET fireside chat - Stock Titan
Krystal Biotech stock hits 52-week high at 213.09 USD By Investing.com - Investing.com India
Evercore ISI Reiterates Buy Rating on Krystal Biotech (KRYS), Sets $218 PT - MSN
How Investors Are Reacting To Krystal Biotech (KRYS) Surging Revenue and Global VYJUVEK Expansion - sahmcapital.com
Krystal Biotech stock hits 52-week high at 213.09 USD - Investing.com
Will Krystal Biotech Inc. stock outperform Nasdaq indexWeekly Trading Summary & Stock Portfolio Risk Control - newser.com
Krystal Biotech (KRYS) Secures FDA Orphan Status for Hailey-Hail - GuruFocus
Why Krystal Biotech Inc. (4KB) stock is a must watch tickerAnalyst Upgrade & Technical Pattern Based Signals - newser.com
How strong dollar benefits Krystal Biotech Inc. (4KB) stock2025 Support & Resistance & Weekly Momentum Picks - newser.com
Is Krystal Biotech Inc. stock a defensive play in 2025July 2025 Macro Moves & Daily Growth Stock Investment Tips - newser.com
Can Krystal Biotech Inc. stock sustain market leadershipJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Can Krystal Biotech Inc. (4KB) stock expand revenue streamsEarnings Recap Summary & Weekly High Return Stock Opportunities - newser.com
Can Krystal Biotech Inc. hit a new high this monthJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
Can Krystal Biotech Inc. (4KB) stock sustain revenue momentumJuly 2025 Retail & Verified Momentum Watchlists - newser.com
How Krystal Biotech Inc. (4KB) stock reacts to weak economyQuarterly Profit Review & Daily Price Action Insights - newser.com
Is Krystal Biotech Inc. stock gaining market shareWeekly Trade Recap & Fast Entry High Yield Tips - newser.com
What analysts say about Krystal Biotech Inc 4KB stockAutomated Trading Signals & Superior Growth Investment - earlytimes.in
Is it time to cut losses on Krystal Biotech Inc.Market Performance Recap & High Accuracy Swing Entry Alerts - newser.com
Is Krystal Biotech Inc. stock ready for a breakoutQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com
Visual analytics tools that track Krystal Biotech Inc. performanceChart Signals & Safe Entry Point Alerts - newser.com
Krystal Biotech Inc Stock (KRYS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):